Tracheo Esophageal FistulaNCT04507295
Cerebral Blood Flow in Neonates During Thoracoscopic Surgeries
A study testing cerebral oximetry ( INVOS 5100 ) in people with Tracheo Esophageal Fistula and Congenital Diaphragmatic Hernia, run by Cairo University.
Trial summary
the aim of this study is to compare the effect of different modes of mechanical ventilation by using volume-controlled ventilation and pressure-controlled ventilation on cerebral blood flow monitored by cerebral oximetry during thoracoscopic surgeries in neonates. Read more about this study
- Who is it for?
- Ages 1 day to 30 days
- Conditions the study is for
- Tracheo Esophageal Fistula, Congenital Diaphragmatic Hernia
- What is being tested?
- cerebral oximetry ( INVOS 5100 )
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 8 Aug 2020to 15 Nov 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 day to 30 days
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- full term neonates
- body weight more than 2500 gm
Who cannot join
- parents' refusal
- preterm neonates
- body weight less than 2500 gm
- congenital cardiac condition
- active chest condition
- congenital neurological diseases
- abnormal kidney and liver function tests
Trial locations and contacts
No sites are listed yet.
About this study
Official title: the Effect of Different Modes of Mechanical Ventilation on Cerebral Blood Flow During Thoracoscopic Surgeries in Neonates (RCT)
the aim of this study is to compare the effect of different modes of mechanical ventilation by using volume-controlled ventilation and pressure-controlled ventilation on cerebral blood flow monitored by cerebral oximetry during thoracoscopic surgeries in neonates.
Read the detailed description
The brain uses aerobic metabolism exclusively for energy production, so the brain is critically dependent on the nearly continuous delivery of oxygen to maintain cellular energy production. Normal cerebral blood flow is approximately 50 ml/100 gram of brain tissue/min. The brain represents 2% of the total body weight but it receives about 15% of the cardiac output. The brain is supplied by the circle of Willis which is formed of anastomosis between the internal carotid artery and the vertebro-basillar system. Monitoring of the CBF depends on either assessing the blood flow itself (e.g, radioactive substance and transcranial duplex) or assessing the oxygen delivery to the brain (e.g, cerebral oximetry and jugular bulb venous O2 saturation). CBF monitoring is an important parameter in both Intensive care unit and operation room in several aspects e.g, traumatic brain injury (TBI), acute stroke, carotid artery surgeries and cardiopulmonary bypass.
Cerebral oximetry is a continuous noninvasive technique that monitors the cerebral blood flow with several advantages over other CBF monitors including the ease of use and interpretation. It is painless and does not utilize ionizing radiation. The recordings provide real time information rather than single static measurements. Using the cerebral oximetry has few limitations including representing local rather than global CBF and absence of normal and cutoff values.
Thoracoscopic surgery was first introduced in 1910 and allowed a major advance in the field of thoracic surgery. Then with the improvement of the Instrumentation, thoracoscopic surgery started in the pediatric field in 1976 for simple procedures and now it is used predominantly in the pediatric thoracic surgery. The use of thoracoscope has many advantages over the open approach including using a smaller incision and reducing blood loss, postoperative pain, hospital stay and musculoskeletal deformities. Thoracoscope utilizes either one lung ventilation (OLV) or CO2 insufflation technique. In neonates the OLV technique is not suitable, so CO2 insufflation ( capnothorax ) is usually used.
Several studies were done and revealed the effect of thoracoscopy in neonate on CBF due to the effect of capnothorax which increases the intrathoracic pressure leading to decreased venous return and cardiac output, subsequently the CBF decreases, and with the increase of the insufflation pressure the decease in the CBF becomes more significant. Also the capnothorax may lead to hypercapnia which leads to changes in the CBF.
The incidence of newborn with congenital anomalies that require surgical procedure during the neonatal period is not low. With the increase of the survival rate, several studies proved that exposure of the neonates to surgery and anesthesia is associated with a higher risk of neuro-developmental delay in different aspects (sensory, motor, language, behavioral, cognitive, etc.) and thoracoscopic surgery is associated with higher risk due to the nature of the disease and the surgery. Using cerebral oximetry in addition to other routine monitors is of added value to maintain CBF within normal range to decrease the incidence of neurological injuries.
There are few studies showing that using different modes of mechanical ventilation affects CBF in neonates due to difference in several factors including effect on hemodynamics and airway pressure but there is no study comparing between volume controlled ventilation and pressure controlled ventilation. This research gap encourages us to do this study.
Preoperative assessment will be conducted on the patients the day before surgery including history taking from parents, full examination, routine laboratory investigations; in the form of CBC, coagulation profile, creatinine, urea, ALT, AST and radiological investigations; in the form of chest X-ray and echocardiography. the parents (guardians) will be consented to be included in the study \& informed about the required fasting hours.
The patients enrolled in the study will be monitored all through the surgical procedure using pulse oximeter, non-invasive blood pressure and invasive blood pressure monitor (also for repeated arterial blood gases sampling), ECG, capnogram in addition to the cerebral oximetry.
Two infant probes of the cerebral oximetry will be applied to the patient on the both sides of the forehead and the monitor will display the cerebral oxygen saturation from the right and the left side of the brain digitally and in form of graph then the baseline reading of the cerebral oxygen saturation will be recorded before induction of anaesthesia.
Induction of general anaesthesia will be performed using a regimen of 1-2 µg/Kg fentanyl IV and 2-3mg/kg propofol IV then tracheal intubation is facilitated using atracurium 0.5 mg/kg IV. Ventilation will be mechanically controlled using the routine pressure-controlled mode, to maintain end tidal CO2 (ETCO2) between 30-35 mmHg.
Anaesthesia will be maintained using 1.6 % isoflurane that will be adjusted according to hemodynamics changes with top up doses of atracurium as required. After starting of gas insufflation using pressure of 4-6 mmHg and flow at 0.5 to 1.0 Liter/Minute, ventilation of patients will be modified according to the protocol of each group.
Recorded data will be analyzed using the statistical package for social sciences, version 20.0 (SPSS Inc., Chicago, Illinois, USA). Quantitative data will be expressed as mean± standard deviation (SD). Qualitative data will be expressed as frequency and percentage. The following tests will be done:
- Independent-samples t-test of significance will be used when comparing between two means.
- Mann Whitney U test: for two-group comparisons in non-parametric data.
- Chi-square (x2) test of significance will be used to compare proportions between qualitative parameters.
- The confidence interval is set to 95% and the margin of error accepted is set to 5%. So, the p-value is considered significant as the following:
- Probability (P-value) :- P-value <0.05 is considered significant. P-value <0.001 is considered as highly significant. P-value >0.05 is considered insignificant.
Sample size was calculated using G-power software. The cerebral oxygen saturation in neonates undergoing thoracoscopic surgery was derived from a previous study and was 73%±7 %.we assumed that different ventilation mode caused a difference of 10% in cerebral oxygen saturation .considering a study power of 80% and a p-value of 0.05 to be significant, the sample size was calculated to be 30 patients (15 in each group)
- Being tested
- cerebral oximetry ( INVOS 5100 )
- Keywords
- neonates, cerebral blood flow, cerebral oximetry, VATS, VCV, PCV, ventilation
- Medical subject headings
- Tracheoesophageal Fistula, Hernias, Diaphragmatic, Congenital, Respiratory Aspiration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cerebral oximetry ( INVOS 5100 )Device
in case of critical cerebra desaturation occurred which is defined as decrease in cerebral saturation by 20% from the base line the following will be done
- Increase FIO2 up to 100%
- Increase PEEP up to 5 cmH2O
- Decrease insufflation pressure
| Study group | Role | What they receive |
|---|---|---|
| volume controlled group | Active comparator | 15 patients in is this group will be ventilated during capnothorax using volume controlled ventilation with the following parameters:
* FIO2 of 60 %.
* Tidal Volume (TV) of 6-8 ml/kg.
* Respiratory rate of 30 breathes/min then the respiratory rate will be modified to maintain the ETCO2 between 30-35 mm Hg.
* inspiratory to expiratory ratio (I: E) 1:2.
* using a minimal Positive End Expiratory Pressure (PEEP) of 2 cm H2O. Receives: Device: cerebral oximetry ( INVOS 5100 ) |
| pressure controlled group | Active comparator | 15 patients in is this group will be ventilated during capnothorax using pressure controlled ventilation with the following parameters:
* FIO2 60 %.
* inspiratory pressure adjusted to fulfil the required TV according to the weight of the patient (6-8 ml /kg) then the insufflation pressure will be added to the driving pressure.
* respiratory rate of 30 breathes/min then the respiratory rate will be modified to maintain the ETCO2 between 30-35 mm Hg.
* I:E ratio of 1:1.5 .
* Using a minimal PEEP of 2 cm H2O. Receives: Device: cerebral oximetry ( INVOS 5100 ) |
What is being measured
The primary outcome is the main question the study is designed to answer.
cerebral saturation
the cerebral oxygen saturation ( % ) will be measured using the cerebral oximetry(INVOS 5100) and will be recorded before induction of anesthesia then every 15 minutes after induction of anesthesia and any attack of cerebral desaturation is recorded
Measured: during the whole duration of surgery
Secondary outcomes (5)
oxygen saturation ( SPO2 )
recorded before induction of anesthesia then every 15 minutes after induction of anesthesia
Measured: during the whole duration of surgery
arterial partial pressure of carbon dioxide ( PaCO2 )
recorded before induction of anesthesia then every 30 minutes after induction of anesthesia
Measured: during the whole duration of surgery
End Tidal CO2 ( ETCO2 )
recorded after induction of anesthesia then every 15 minutes
Measured: during the whole duration of surgery
Positive End Expiratory Pressure ( PEEP )
any changes in PEEP in case of cerebral desaturation will be recorded
Measured: during the whole duration of surgery
Fraction of inspired oxygen
any changes in FIO2 in case of cerebral desaturation will be recorded
Measured: during the whole duration of surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Aug 2020
- Study start8 Aug 2020 (estimated)
- Primary completion8 Nov 2020 (estimated)
- Study completion15 Nov 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Tracheo Esophageal FistulaStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hussam Hassan, Cairo University
- Investigators
- Amel H Abo Elela, Prof, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04507295
- Sponsor's protocol ID
- MS-271-2019
- Status last verified
- Aug 2020
- First submitted
- 5 Aug 2020
- Last updated
- 11 Aug 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Publications
Kirkness CJ. Cerebral blood flow monitoring in clinical practice. AACN Clin Issues. 2005 Oct-Dec;16(4):476-87. doi: 10.1097/00044067-200510000-00005.
PubMed 16269893Woitzik J, Dreier JP, Hecht N, Fiss I, Sandow N, Major S, Winkler M, Dahlem YA, Manville J, Diepers M, Muench E, Kasuya H, Schmiedek P, Vajkoczy P; COSBID study group. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012 Feb;32(2):203-12. doi: 10.1038/jcbfm.2011.169. Epub 2011 Dec 7.
PubMed 22146193Meng L, Hou W, Chui J, Han R, Gelb AW. Cardiac Output and Cerebral Blood Flow: The Integrated Regulation of Brain Perfusion in Adult Humans. Anesthesiology. 2015 Nov;123(5):1198-208. doi: 10.1097/ALN.0000000000000872.
PubMed 26402848Friedman JA, Anderson RE, Meyer FB. Techniques of intraoperative cerebral blood flow measurement. Neurosurg Focus. 2000 Nov 15;9(5):e4. doi: 10.3171/foc.2000.9.5.4.
PubMed 16821756Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009 Dec;103 Suppl 1:i3-13. doi: 10.1093/bja/aep299.
PubMed 20007987Kumar K, Basker S, Jeslin L, Karthikeyan C, Matthias A. Anaesthesia for pediatric video assisted thoracoscopic surgery. J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):12-6. No abstract available.
PubMed 21804698Shah R, Reddy AS, Dhende NP. Video assisted thoracic surgery in children. J Minim Access Surg. 2007 Oct;3(4):161-7. doi: 10.4103/0972-9941.38910.
PubMed 19789677Dave N, Fernandes S. Anaesthetic implications of paediatric thoracoscopy. J Minim Access Surg. 2005 Mar;1(1):8-14. doi: 10.4103/0972-9941.15240.
PubMed 21234138Tytgat SH, van Herwaarden MY, Stolwijk LJ, Keunen K, Benders MJ, de Graaff JC, Milstein DM, van der Zee DC, Lemmers PM. Neonatal brain oxygenation during thoracoscopic correction of esophageal atresia. Surg Endosc. 2016 Jul;30(7):2811-7. doi: 10.1007/s00464-015-4559-1. Epub 2015 Oct 21.
PubMed 26490769
Study at a glance
From the registry record, last updated by the sponsor on 11 Aug 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- the Effect of Different Modes of Mechanical Ventilation on Cerebral Blood Flow During Thoracoscopic Surgeries in Neonates (RCT)
- ClinicalTrials.gov ID
- NCT04507295
- Acronym / sponsor ID
- MS-271-2019
- Keywords
- neonates, cerebral blood flow, cerebral oximetry, VATS, VCV, PCV, ventilation
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 8 Aug 2020 (estimated)
- Primary completion
- 8 Nov 2020 (estimated)
- Study completion
- 15 Nov 2020 (estimated)
- First posted
- 11 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
the aim of this study is to compare the effect of different modes of mechanical ventilation by using volume-controlled ventilation and pressure-controlled ventilation on cerebral blood flow monitored by cerebral oximetry during thoracoscopic surgeries in neonates.
Detailed description
The brain uses aerobic metabolism exclusively for energy production, so the brain is critically dependent on the nearly continuous delivery of oxygen to maintain cellular energy production. Normal cerebral blood flow is approximately 50 ml/100 gram of brain tissue/min. The brain represents 2% of the total body weight but it receives about 15% of the cardiac output. The brain is supplied by the circle of Willis which is formed of anastomosis between the internal carotid artery and the vertebro-basillar system. Monitoring of the CBF depends on either assessing the blood flow itself (e.g, radioactive substance and transcranial duplex) or assessing the oxygen delivery to the brain (e.g, cerebral oximetry and jugular bulb venous O2 saturation). CBF monitoring is an important parameter in both Intensive care unit and operation room in several aspects e.g, traumatic brain injury (TBI), acute stroke, carotid artery surgeries and cardiopulmonary bypass.
Cerebral oximetry is a continuous noninvasive technique that monitors the cerebral blood flow with several advantages over other CBF monitors including the ease of use and interpretation. It is painless and does not utilize ionizing radiation. The recordings provide real time information rather than single static measurements. Using the cerebral oximetry has few limitations including representing local rather than global CBF and absence of normal and cutoff values.
Thoracoscopic surgery was first introduced in 1910 and allowed a major advance in the field of thoracic surgery. Then with the improvement of the Instrumentation, thoracoscopic surgery started in the pediatric field in 1976 for simple procedures and now it is used predominantly in the pediatric thoracic surgery. The use of thoracoscope has many advantages over the open approach including using a smaller incision and reducing blood loss, postoperative pain, hospital stay and musculoskeletal deformities. Thoracoscope utilizes either one lung ventilation (OLV) or CO2 insufflation technique. In neonates the OLV technique is not suitable, so CO2 insufflation ( capnothorax ) is usually used.
Several studies were done and revealed the effect of thoracoscopy in neonate on CBF due to the effect of capnothorax which increases the intrathoracic pressure leading to decreased venous return and cardiac output, subsequently the CBF decreases, and with the increase of the insufflation pressure the decease in the CBF becomes more significant. Also the capnothorax may lead to hypercapnia which leads to changes in the CBF.
The incidence of newborn with congenital anomalies that require surgical procedure during the neonatal period is not low. With the increase of the survival rate, several studies proved that exposure of the neonates to surgery and anesthesia is associated with a higher risk of neuro-developmental delay in different aspects (sensory, motor, language, behavioral, cognitive, etc.) and thoracoscopic surgery is associated with higher risk due to the nature of the disease and the surgery. Using cerebral oximetry in addition to other routine monitors is of added value to maintain CBF within normal range to decrease the incidence of neurological injuries.
There are few studies showing that using different modes of mechanical ventilation affects CBF in neonates due to difference in several factors including effect on hemodynamics and airway pressure but there is no study comparing between volume controlled ventilation and pressure controlled ventilation. This research gap encourages us to do this study.
Preoperative assessment will be conducted on the patients the day before surgery including history taking from parents, full examination, routine laboratory investigations; in the form of CBC, coagulation profile, creatinine, urea, ALT, AST and radiological investigations; in the form of chest X-ray and echocardiography. the parents (guardians) will be consented to be included in the study \& informed about the required fasting hours.
The patients enrolled in the study will be monitored all through the surgical procedure using pulse oximeter, non-invasive blood pressure and invasive blood pressure monitor (also for repeated arterial blood gases sampling), ECG, capnogram in addition to the cerebral oximetry.
Two infant probes of the cerebral oximetry will be applied to the patient on the both sides of the forehead and the monitor will display the cerebral oxygen saturation from the right and the left side of the brain digitally and in form of graph then the baseline reading of the cerebral oxygen saturation will be recorded before induction of anaesthesia.
Induction of general anaesthesia will be performed using a regimen of 1-2 µg/Kg fentanyl IV and 2-3mg/kg propofol IV then tracheal intubation is facilitated using atracurium 0.5 mg/kg IV. Ventilation will be mechanically controlled using the routine pressure-controlled mode, to maintain end tidal CO2 (ETCO2) between 30-35 mmHg.
Anaesthesia will be maintained using 1.6 % isoflurane that will be adjusted according to hemodynamics changes with top up doses of atracurium as required. After starting of gas insufflation using pressure of 4-6 mmHg and flow at 0.5 to 1.0 Liter/Minute, ventilation of patients will be modified according to the protocol of each group.
Recorded data will be analyzed using the statistical package for social sciences, version 20.0 (SPSS Inc., Chicago, Illinois, USA). Quantitative data will be expressed as mean± standard deviation (SD). Qualitative data will be expressed as frequency and percentage. The following tests will be done:
- Independent-samples t-test of significance will be used when comparing between two means.
- Mann Whitney U test: for two-group comparisons in non-parametric data.
- Chi-square (x2) test of significance will be used to compare proportions between qualitative parameters.
- The confidence interval is set to 95% and the margin of error accepted is set to 5%. So, the p-value is considered significant as the following:
- Probability (P-value) :- P-value <0.05 is considered significant. P-value <0.001 is considered as highly significant. P-value >0.05 is considered insignificant.
Sample size was calculated using G-power software. The cerebral oxygen saturation in neonates undergoing thoracoscopic surgery was derived from a previous study and was 73%±7 %.we assumed that different ventilation mode caused a difference of 10% in cerebral oxygen saturation .considering a study power of 80% and a p-value of 0.05 to be significant, the sample size was calculated to be 30 patients (15 in each group)
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| volume controlled group | Active comparator | Device: cerebral oximetry ( INVOS 5100 )15 patients in is this group will be ventilated during capnothorax using volume controlled ventilation with the following parameters: * FIO2 of 60 %. * Tidal Volume (TV) of 6-8 ml/kg. * Respiratory rate of 30 breathes/min then the respiratory rate will be modified to maintain the ETCO2 between 30-35 mm Hg. * inspiratory to expiratory ratio (I: E) 1:2. * using a minimal Positive End Expiratory Pressure (PEEP) of 2 cm H2O. |
| pressure controlled group | Active comparator | Device: cerebral oximetry ( INVOS 5100 )15 patients in is this group will be ventilated during capnothorax using pressure controlled ventilation with the following parameters: * FIO2 60 %. * inspiratory pressure adjusted to fulfil the required TV according to the weight of the patient (6-8 ml /kg) then the insufflation pressure will be added to the driving pressure. * respiratory rate of 30 breathes/min then the respiratory rate will be modified to maintain the ETCO2 between 30-35 mm Hg. * I:E ratio of 1:1.5 . * Using a minimal PEEP of 2 cm H2O. |
Who may qualify
- Ages
- 1 day to 30 days
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- full term neonates
- body weight more than 2500 gm
Key exclusion criteria (7 listed)
- parents' refusal
- preterm neonates
- body weight less than 2500 gm
- congenital cardiac condition
- active chest condition
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cerebral oximetry ( INVOS 5100 )in case of critical cerebra desaturation occurred which is defined as decrease in cerebral saturation by 20% from the base line the following will be done 1. Increase FIO2 up to 100% 2. Increase PEEP up to 5 cmH2O 3. Decrease insufflation pressure | Device | pressure controlled group, volume controlled group |
Primary outcome
cerebral saturation
Time frame: during the whole duration of surgery
the cerebral oxygen saturation ( % ) will be measured using the cerebral oximetry(INVOS 5100) and will be recorded before induction of anesthesia then every 15 minutes after induction of anesthesia and any attack of cerebral desaturation is recorded
5 secondary outcomes
oxygen saturation ( SPO2 )
Time frame: during the whole duration of surgery
arterial partial pressure of carbon dioxide ( PaCO2 )
Time frame: during the whole duration of surgery
End Tidal CO2 ( ETCO2 )
Time frame: during the whole duration of surgery
Positive End Expiratory Pressure ( PEEP )
Time frame: during the whole duration of surgery
Fraction of inspired oxygen
Time frame: during the whole duration of surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Aug 2020.
- Background: PubMed 16269893Kirkness CJ. Cerebral blood flow monitoring in clinical practice. AACN Clin Issues. 2005 Oct-Dec;16(4):476-87. doi: 10.1097/00044067-200510000-00005.
- Background: PubMed 22146193Woitzik J, Dreier JP, Hecht N, Fiss I, Sandow N, Major S, Winkler M, Dahlem YA, Manville J, Diepers M, Muench E, Kasuya H, Schmiedek P, Vajkoczy P; COSBID study group. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012 Feb;32(2):203-12. doi: 10.1038/jcbfm.2011.169. Epub 2011 Dec 7.
- Background: PubMed 26402848Meng L, Hou W, Chui J, Han R, Gelb AW. Cardiac Output and Cerebral Blood Flow: The Integrated Regulation of Brain Perfusion in Adult Humans. Anesthesiology. 2015 Nov;123(5):1198-208. doi: 10.1097/ALN.0000000000000872.
- Background: PubMed 16821756Friedman JA, Anderson RE, Meyer FB. Techniques of intraoperative cerebral blood flow measurement. Neurosurg Focus. 2000 Nov 15;9(5):e4. doi: 10.3171/foc.2000.9.5.4.
- Background: PubMed 20007987Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009 Dec;103 Suppl 1:i3-13. doi: 10.1093/bja/aep299.
- Background: PubMed 21804698Kumar K, Basker S, Jeslin L, Karthikeyan C, Matthias A. Anaesthesia for pediatric video assisted thoracoscopic surgery. J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):12-6. No abstract available.
- Background: PubMed 19789677Shah R, Reddy AS, Dhende NP. Video assisted thoracic surgery in children. J Minim Access Surg. 2007 Oct;3(4):161-7. doi: 10.4103/0972-9941.38910.
- Background: PubMed 21234138Dave N, Fernandes S. Anaesthetic implications of paediatric thoracoscopy. J Minim Access Surg. 2005 Mar;1(1):8-14. doi: 10.4103/0972-9941.15240.
- Background: PubMed 26490769Tytgat SH, van Herwaarden MY, Stolwijk LJ, Keunen K, Benders MJ, de Graaff JC, Milstein DM, van der Zee DC, Lemmers PM. Neonatal brain oxygenation during thoracoscopic correction of esophageal atresia. Surg Endosc. 2016 Jul;30(7):2811-7. doi: 10.1007/s00464-015-4559-1. Epub 2015 Oct 21.
Related trials for Tracheo Esophageal Fistula
RecruitingObservational study
Camera-based Endoscopy Allows Spontaneous Breathing Diagnostic Management in Neonates With Tracheoesophageal Fistula
Tracheoesophageal Fistula, Esophageal Atresia With Tracheo-esophageal Fistula
Recruiting
Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study
Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Atresia
RecruitingObservational study
An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels
Gastroschisis, Congenital Diaphragmatic Hernia
Enrolling by invitation
Primary Posterior Tracheopexy Prevents Tracheal Collapse
Oesophageal Atresia With Tracheo-Oesophageal Fistula, Tracheomalacia
Active, not recruiting
Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair
Esophageal Atresia, Tracheoesophageal Fistula
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amel H Abo Elela, Prof principal investigator
Cairo University
Questions about this trial
What is this clinical trial studying?
A study testing cerebral oximetry ( INVOS 5100 ) in people with Tracheo Esophageal Fistula and Congenital Diaphragmatic Hernia, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 11 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Nasr M Abdallah, Assist. Prof (00201005223734, sief.nasr@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
cerebral saturation (time frame: during the whole duration of surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04507295, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2020.